These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
450 related articles for article (PubMed ID: 30571551)
1. Immunoproteasome Subunit β5i Promotes Ang II (Angiotensin II)-Induced Atrial Fibrillation by Targeting ATRAP (Ang II Type I Receptor-Associated Protein) Degradation in Mice. Li J; Wang S; Zhang YL; Bai J; Lin QY; Liu RS; Yu XH; Li HH Hypertension; 2019 Jan; 73(1):92-101. PubMed ID: 30571551 [TBL] [Abstract][Full Text] [Related]
2. Melatonin inhibits angiotensin II-induced atrial fibrillation through preventing degradation of Ang II Type I Receptor-Associated Protein (ATRAP). Xie X; Shen TT; Bi HL; Su ZL; Liao ZQ; Zhang Y; Shi L; Xia YL Biochem Pharmacol; 2022 Aug; 202():115146. PubMed ID: 35710020 [TBL] [Abstract][Full Text] [Related]
3. Ablation of Immunoproteasome β5i Subunit Suppresses Hypertensive Retinopathy by Blocking ATRAP Degradation in Mice. Wang S; Li J; Wang T; Bai J; Zhang YL; Lin QY; Li JM; Zhao Q; Guo SB; Li HH Mol Ther; 2020 Jan; 28(1):279-292. PubMed ID: 31636038 [TBL] [Abstract][Full Text] [Related]
4. Novel Role for the Immunoproteasome Subunit PSMB10 in Angiotensin II-Induced Atrial Fibrillation in Mice. Li J; Wang S; Bai J; Yang XL; Zhang YL; Che YL; Li HH; Yang YZ Hypertension; 2018 May; 71(5):866-876. PubMed ID: 29507100 [TBL] [Abstract][Full Text] [Related]
5. Genetic ablation and pharmacological inhibition of immunosubunit β5i attenuates cardiac remodeling in deoxycorticosterone-acetate (DOCA)-salt hypertensive mice. Cao HJ; Fang J; Zhang YL; Zou LX; Han X; Yang J; Yan X; Li PB; Wang HX; Guo SB; Li HH J Mol Cell Cardiol; 2019 Dec; 137():34-45. PubMed ID: 31629736 [TBL] [Abstract][Full Text] [Related]
6. Dapagliflozin: A sodium-glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced atrial fibrillation by regulating atrial electrical and structural remodeling. Zhan G; Wang X; Wang X; Li J; Tang Y; Bi H; Yang X; Xia Y Eur J Pharmacol; 2024 Sep; 978():176712. PubMed ID: 38906237 [TBL] [Abstract][Full Text] [Related]
7. Activation of the cardiac proteasome promotes angiotension II-induced hypertrophy by down-regulation of ATRAP. Li N; Wang HX; Han QY; Li WJ; Zhang YL; Du J; Xia YL; Li HH J Mol Cell Cardiol; 2015 Feb; 79():303-14. PubMed ID: 25526681 [TBL] [Abstract][Full Text] [Related]
8. Activated factor X stimulates atrial endothelial cells and tissues to promote remodelling responses through AT1R/NADPH oxidases/SGLT1/2. Fakih W; Mroueh A; Gong DS; Kikuchi S; Pieper MP; Kindo M; Mazzucottelli JP; Mommerot A; Kanso M; Ohlmann P; Morel O; Schini-Kerth V; Jesel L Cardiovasc Res; 2024 Sep; 120(10):1138-1154. PubMed ID: 38742661 [TBL] [Abstract][Full Text] [Related]
9. Administration of USP7 inhibitor p22077 alleviates Angiotensin II (Ang II)-induced atrial fibrillation in Mice. Wang Y; Gu YH; Ren KW; Xie X; Wang SH; Zhu XX; Wang L; Yang XL; Bi HL Hypertens Res; 2024 May; 47(5):1309-1322. PubMed ID: 38374239 [TBL] [Abstract][Full Text] [Related]
10. NPR-C (Natriuretic Peptide Receptor-C) Modulates the Progression of Angiotensin II-Mediated Atrial Fibrillation and Atrial Remodeling in Mice. Jansen HJ; Mackasey M; Moghtadaei M; Liu Y; Kaur J; Egom EE; Tuomi JM; Rafferty SA; Kirkby AW; Rose RA Circ Arrhythm Electrophysiol; 2019 Jan; 12(1):e006863. PubMed ID: 30636477 [TBL] [Abstract][Full Text] [Related]
11. Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7. He X; Gao X; Peng L; Wang S; Zhu Y; Ma H; Lin J; Duan DD Circ Res; 2011 Jan; 108(2):164-75. PubMed ID: 21127293 [TBL] [Abstract][Full Text] [Related]
12. Platelets Promote Ang II (Angiotensin II)-Induced Atrial Fibrillation by Releasing TGF-β1 (Transforming Growth Factor-β1) and Interacting With Fibroblasts. Liu Y; Lv H; Tan R; An X; Niu XH; Liu YJ; Yang X; Yin X; Xia YL Hypertension; 2020 Dec; 76(6):1856-1867. PubMed ID: 33175633 [TBL] [Abstract][Full Text] [Related]
13. Elevated expression of connective tissue growth factor in human atrial fibrillation and angiotensin II-treated cardiomyocytes. Ko WC; Hong CY; Hou SM; Lin CH; Ong ET; Lee CF; Tsai CT; Lai LP Circ J; 2011; 75(7):1592-600. PubMed ID: 21576830 [TBL] [Abstract][Full Text] [Related]
14. Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury. Yagi S; Akaike M; Aihara K; Ishikawa K; Iwase T; Ikeda Y; Soeki T; Yoshida S; Sumitomo-Ueda Y; Matsumoto T; Sata M Hypertension; 2010 Apr; 55(4):918-23. PubMed ID: 20194307 [TBL] [Abstract][Full Text] [Related]
15. LncRNA PVT1 regulates atrial fibrosis via miR-128-3p-SP1-TGF-β1-Smad axis in atrial fibrillation. Cao F; Li Z; Ding WM; Yan L; Zhao QY Mol Med; 2019 Mar; 25(1):7. PubMed ID: 30894138 [TBL] [Abstract][Full Text] [Related]
16. The crucial role of activin A/ALK4 pathway in the pathogenesis of Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation. Wang Q; Yu Y; Zhang P; Chen Y; Li C; Chen J; Wang Y; Li Y Basic Res Cardiol; 2017 Jul; 112(4):47. PubMed ID: 28639003 [TBL] [Abstract][Full Text] [Related]
17. MFGE8 attenuates Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation through inhibition of TGF-β1/Smad2/3 pathway. Ge Z; Chen Y; Wang B; Zhang X; Yan Y; Zhou L; Zhang Y; Xie Y J Mol Cell Cardiol; 2020 Feb; 139():164-175. PubMed ID: 31958465 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin II Regulates Th1 T Cell Differentiation Through Angiotensin II Type 1 Receptor-PKA-Mediated Activation of Proteasome. Qin XY; Zhang YL; Chi YF; Yan B; Zeng XJ; Li HH; Liu Y Cell Physiol Biochem; 2018; 45(4):1366-1376. PubMed ID: 29462804 [TBL] [Abstract][Full Text] [Related]
19. Gallic Acid Ameliorates Angiotensin II-Induced Atrial Fibrillation by Inhibiting Immunoproteasome- Mediated PTEN Degradation in Mice. Han D; Zhang QY; Zhang YL; Han X; Guo SB; Teng F; Yan X; Li HH Front Cell Dev Biol; 2020; 8():594683. PubMed ID: 33251220 [TBL] [Abstract][Full Text] [Related]
20. Neferine mitigates angiotensin II-induced atrial fibrillation and fibrosis via upregulation of Nrf2/HO-1 and inhibition of TGF-β/p-Smad2/3 pathways. Jiang XX; Zhang R; Wang HS Aging (Albany NY); 2024 May; 16(10):8630-8644. PubMed ID: 38775722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]